Chi-Him Thomas Cheung
Direktor/Vorstandsmitglied bei Triley Bidco Ltd.
Profil
Chi-Him Thomas Cheung is currently a Director at Triley Bidco Ltd.
He was previously a Director at Clinigen Ltd.
from 2022 to 2023.
Aktive Positionen von Chi-Him Thomas Cheung
Unternehmen | Position | Beginn |
---|---|---|
Triley Bidco Ltd.
Triley Bidco Ltd. Financial ConglomeratesFinance Triley Bidco Ltd. is an investment holding British company founded in 2021. The private company is based in London, UK. and has a global presence of subsidiaries in several regions. Triley Bidco functions as an investment holding company. | Direktor/Vorstandsmitglied | 19.11.2021 |
Ehemalige bekannte Positionen von Chi-Him Thomas Cheung
Unternehmen | Position | Ende |
---|---|---|
CLINIGEN GROUP PLC | Direktor/Vorstandsmitglied | 03.01.2023 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Triley Bidco Ltd.
Triley Bidco Ltd. Financial ConglomeratesFinance Triley Bidco Ltd. is an investment holding British company founded in 2021. The private company is based in London, UK. and has a global presence of subsidiaries in several regions. Triley Bidco functions as an investment holding company. | Finance |
Clinigen Ltd.
Clinigen Ltd. Miscellaneous Commercial ServicesCommercial Services Clinigen Ltd. engages in the provision of pharmaceutical products and services. It operates through the following segments: Commercial Medicines, Unlicensed Medicines, and Clinical Trial Services. The Commercial Medicines segment acquires rights to niche hospital-only and critical care products and also provides access to licensed and branded generic. The Unlicensed Medicines segment supplies unlicensed medicines to hospital pharmacists and physicians for patients with a high unmet medical need. The Clinical Trial Services offers comparator medicines and services to clinical trials and IITs. The company was founded by Andrew Leaver in June 2010 and is headquartered in Burton-on-Trent, the United Kingdom. | Commercial Services |